{"entity":{"type":"insider","cik":"0001891900","url":"/insider/0001891900","json_url":"/insider/0001891900.json","name":"Teehan Brendan","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":16,"n_filings":16,"first":"2022-01-10","last":"2024-11-19","span_basis":"filed_date"},"name_variants":[{"name":"Teehan Brendan","source":"filing","n_filings":16,"first_seen":"2022-01-10","last_seen":"2024-11-19"}],"transactions":[{"id":2565521,"accession":"0001415889-24-027294","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001415889-24-027294","line_url":"/filing/0001415889-24-027294#line-3","is_derivative":false,"issuer_cik":"0001070494","issuer_name":"ACADIA PHARMACEUTICALS INC","issuer_ticker":"ACAD","issuer_name_source":null,"issuer_url":"/issuer/0001070494","owner_cik":"0001891900","owner_name":"Teehan Brendan","owner_display_name":"Teehan Brendan","owner_url":"/insider/0001891900","role":"Officer (EVP, COO, HEAD OF COMMERCIAL)","role_mark":"O","role_mark_label":"Officer (EVP, COO, HEAD OF COMMERCIAL)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, COO, HEAD OF COMMERCIAL","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10329.0,"shares_display":"10,329","price_per_share":16.81,"price_display":"16.81","price_state":"stated","total_value":173630.49,"total_display":"173,630.49","total_whole":"173,630","shares_owned_after":62105.0,"shares_owned_after_display":"62,105","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-11-19","filed_date":"2024-11-19","scope":"insider"},{"id":2392133,"accession":"0001415889-24-021726","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001415889-24-021726","line_url":"/filing/0001415889-24-021726#line-3","is_derivative":false,"issuer_cik":"0001070494","issuer_name":"ACADIA PHARMACEUTICALS INC","issuer_ticker":"ACAD","issuer_name_source":null,"issuer_url":"/issuer/0001070494","owner_cik":"0001891900","owner_name":"Teehan Brendan","owner_display_name":"Teehan Brendan","owner_url":"/insider/0001891900","role":"Officer (EVP, COO, HEAD OF COMMERCIAL)","role_mark":"O","role_mark_label":"Officer (EVP, COO, HEAD OF COMMERCIAL)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, COO, HEAD OF COMMERCIAL","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9534.0,"shares_display":"9,534","price_per_share":15.28,"price_display":"15.28","price_state":"stated","total_value":145679.52,"total_display":"145,679.52","total_whole":"145,680","shares_owned_after":52177.0,"shares_owned_after_display":"52,177","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-08-19","filed_date":"2024-08-20","scope":"insider"},{"id":3262419,"accession":"0001415889-24-012239","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-24-012239","line_url":"/filing/0001415889-24-012239#line-2","is_derivative":false,"issuer_cik":"0001070494","issuer_name":"ACADIA PHARMACEUTICALS INC","issuer_ticker":"ACAD","issuer_name_source":null,"issuer_url":"/issuer/0001070494","owner_cik":"0001891900","owner_name":"Teehan Brendan","owner_display_name":"Teehan Brendan","owner_url":"/insider/0001891900","role":"Officer (EVP, COO, HEAD OF COMMERCIAL)","role_mark":"O","role_mark_label":"Officer (EVP, COO, HEAD OF COMMERCIAL)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, COO, HEAD OF COMMERCIAL","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3477.0,"shares_display":"3,477","price_per_share":16.94,"price_display":"16.94","price_state":"stated","total_value":58900.38,"total_display":"58,900.38","total_whole":"58,900","shares_owned_after":42133.0,"shares_owned_after_display":"42,133","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-05-02","filed_date":"2024-05-03","scope":"insider"},{"id":2222164,"accession":"0001415889-24-010603","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-24-010603","line_url":"/filing/0001415889-24-010603#line-2","is_derivative":false,"issuer_cik":"0001070494","issuer_name":"ACADIA PHARMACEUTICALS INC","issuer_ticker":"ACAD","issuer_name_source":null,"issuer_url":"/issuer/0001070494","owner_cik":"0001891900","owner_name":"Teehan Brendan","owner_display_name":"Teehan Brendan","owner_url":"/insider/0001891900","role":"Officer (EVP, COO, HEAD OF COMMERCIAL)","role_mark":"O","role_mark_label":"Officer (EVP, COO, HEAD OF COMMERCIAL)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, COO, HEAD OF COMMERCIAL","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2568.0,"shares_display":"2,568","price_per_share":17.87,"price_display":"17.87","price_state":"stated","total_value":45890.16,"total_display":"45,890.16","total_whole":"45,890","shares_owned_after":38796.0,"shares_owned_after_display":"38,796","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-04-08","filed_date":"2024-04-09","scope":"insider"},{"id":2447199,"accession":"0001415889-24-009272","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-24-009272","line_url":"/filing/0001415889-24-009272#line-2","is_derivative":false,"issuer_cik":"0001070494","issuer_name":"ACADIA PHARMACEUTICALS INC","issuer_ticker":"ACAD","issuer_name_source":null,"issuer_url":"/issuer/0001070494","owner_cik":"0001891900","owner_name":"Teehan Brendan","owner_display_name":"Teehan Brendan","owner_url":"/insider/0001891900","role":"Officer (EVP, COO, HEAD OF COMMERCIAL)","role_mark":"O","role_mark_label":"Officer (EVP, COO, HEAD OF COMMERCIAL)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, COO, HEAD OF COMMERCIAL","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5140.0,"shares_display":"5,140","price_per_share":17.9,"price_display":"17.90","price_state":"stated","total_value":92006.0,"total_display":"92,006.00","total_whole":"92,006","shares_owned_after":36340.0,"shares_owned_after_display":"36,340","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-27","filed_date":"2024-03-27","scope":"insider"},{"id":2522081,"accession":"0001415889-24-005575","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-24-005575","line_url":"/filing/0001415889-24-005575#line-2","is_derivative":false,"issuer_cik":"0001070494","issuer_name":"ACADIA PHARMACEUTICALS INC","issuer_ticker":"ACAD","issuer_name_source":null,"issuer_url":"/issuer/0001070494","owner_cik":"0001891900","owner_name":"Teehan Brendan","owner_display_name":"Teehan Brendan","owner_url":"/insider/0001891900","role":"Officer (EVP, COO, HEAD OF COMMERCIAL)","role_mark":"O","role_mark_label":"Officer (EVP, COO, HEAD OF COMMERCIAL)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, COO, HEAD OF COMMERCIAL","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":624.0,"shares_display":"624","price_per_share":24.67,"price_display":"24.67","price_state":"stated","total_value":15394.08,"total_display":"15,394.08","total_whole":"15,394","shares_owned_after":31432.0,"shares_owned_after_display":"31,432","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-26","filed_date":"2024-02-27","scope":"insider"},{"id":2151304,"accession":"0001209191-24-001268","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-24-001268","line_url":"/filing/0001209191-24-001268#line-2","is_derivative":false,"issuer_cik":"0001070494","issuer_name":"ACADIA PHARMACEUTICALS INC","issuer_ticker":"ACAD","issuer_name_source":null,"issuer_url":"/issuer/0001070494","owner_cik":"0001891900","owner_name":"Teehan Brendan","owner_display_name":"Teehan Brendan","owner_url":"/insider/0001891900","role":"Officer (EVP, COO, Head of Commercial)","role_mark":"O","role_mark_label":"Officer (EVP, COO, Head of Commercial)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, COO, Head of Commercial","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":731.0,"shares_display":"731","price_per_share":29.96,"price_display":"29.96","price_state":"stated","total_value":21900.76,"total_display":"21,900.76","total_whole":"21,901","shares_owned_after":30949.0,"shares_owned_after_display":"30,949","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-08","filed_date":"2024-01-09","scope":"insider"},{"id":8727340,"accession":"0001209191-23-056355","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-23-056355","line_url":"/filing/0001209191-23-056355#line-3","is_derivative":false,"issuer_cik":"0001070494","issuer_name":"ACADIA PHARMACEUTICALS INC","issuer_ticker":"ACAD","issuer_name_source":null,"issuer_url":"/issuer/0001070494","owner_cik":"0001891900","owner_name":"Teehan Brendan","owner_display_name":"Teehan Brendan","owner_url":"/insider/0001891900","role":"Officer (EVP, COO, Head of Commercial)","role_mark":"O","role_mark_label":"Officer (EVP, COO, Head of Commercial)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, COO, Head of Commercial","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4960.0,"shares_display":"4,960","price_per_share":22.64,"price_display":"22.64","price_state":"stated","total_value":112294.4,"total_display":"112,294.40","total_whole":"112,294","shares_owned_after":30393.0,"shares_owned_after_display":"30,393","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-11-20","filed_date":"2023-11-21","scope":"insider"},{"id":8499954,"accession":"0001209191-23-031241","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-23-031241","line_url":"/filing/0001209191-23-031241#line-3","is_derivative":false,"issuer_cik":"0001070494","issuer_name":"ACADIA PHARMACEUTICALS INC","issuer_ticker":"ACAD","issuer_name_source":null,"issuer_url":"/issuer/0001070494","owner_cik":"0001891900","owner_name":"Teehan Brendan","owner_display_name":"Teehan Brendan","owner_url":"/insider/0001891900","role":"Officer (EVP, COO, Head of Commercial)","role_mark":"O","role_mark_label":"Officer (EVP, COO, Head of Commercial)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, COO, Head of Commercial","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14869.0,"shares_display":"14,869","price_per_share":22.5,"price_display":"22.50","price_state":"stated","total_value":334552.5,"total_display":"334,552.50","total_whole":"334,553","shares_owned_after":24356.0,"shares_owned_after_display":"24,356","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-05-17","filed_date":"2023-05-19","scope":"insider"},{"id":8076624,"accession":"0001209191-23-026744","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-026744","line_url":"/filing/0001209191-23-026744#line-2","is_derivative":false,"issuer_cik":"0001070494","issuer_name":"ACADIA PHARMACEUTICALS INC","issuer_ticker":"ACAD","issuer_name_source":null,"issuer_url":"/issuer/0001070494","owner_cik":"0001891900","owner_name":"Teehan Brendan","owner_display_name":"Teehan Brendan","owner_url":"/insider/0001891900","role":"Officer (EVP, COO, Head of Commercial)","role_mark":"O","role_mark_label":"Officer (EVP, COO, Head of Commercial)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, COO, Head of Commercial","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":548.0,"shares_display":"548","price_per_share":21.18,"price_display":"21.18","price_state":"stated","total_value":11606.64,"total_display":"11,606.64","total_whole":"11,607","shares_owned_after":9487.0,"shares_owned_after_display":"9,487","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-05-01","filed_date":"2023-05-02","scope":"insider"},{"id":8679231,"accession":"0001209191-23-023865","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-023865","line_url":"/filing/0001209191-23-023865#line-2","is_derivative":false,"issuer_cik":"0001070494","issuer_name":"ACADIA PHARMACEUTICALS INC","issuer_ticker":"ACAD","issuer_name_source":null,"issuer_url":"/issuer/0001070494","owner_cik":"0001891900","owner_name":"Teehan Brendan","owner_display_name":"Teehan Brendan","owner_url":"/insider/0001891900","role":"Officer (EVP, COO, Head of Commercial)","role_mark":"O","role_mark_label":"Officer (EVP, COO, Head of Commercial)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, COO, Head of Commercial","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1751.0,"shares_display":"1,751","price_per_share":18.16,"price_display":"18.16","price_state":"stated","total_value":31798.16,"total_display":"31,798.16","total_whole":"31,798","shares_owned_after":8468.0,"shares_owned_after_display":"8,468","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-04-06","filed_date":"2023-04-07","scope":"insider"},{"id":7994620,"accession":"0001209191-23-013468","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-013468","line_url":"/filing/0001209191-23-013468#line-2","is_derivative":false,"issuer_cik":"0001070494","issuer_name":"ACADIA PHARMACEUTICALS INC","issuer_ticker":"ACAD","issuer_name_source":null,"issuer_url":"/issuer/0001070494","owner_cik":"0001891900","owner_name":"Teehan Brendan","owner_display_name":"Teehan Brendan","owner_url":"/insider/0001891900","role":"Officer (EVP, COO, Head of Commercial)","role_mark":"O","role_mark_label":"Officer (EVP, COO, Head of Commercial)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, COO, Head of Commercial","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":461.0,"shares_display":"461","price_per_share":18.78,"price_display":"18.78","price_state":"stated","total_value":8657.58,"total_display":"8,657.58","total_whole":"8,658","shares_owned_after":5195.0,"shares_owned_after_display":"5,195","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-24","filed_date":"2023-02-27","scope":"insider"},{"id":8461279,"accession":"0001209191-23-002895","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-002895","line_url":"/filing/0001209191-23-002895#line-2","is_derivative":false,"issuer_cik":"0001070494","issuer_name":"ACADIA PHARMACEUTICALS INC","issuer_ticker":"ACAD","issuer_name_source":null,"issuer_url":"/issuer/0001070494","owner_cik":"0001891900","owner_name":"Teehan Brendan","owner_display_name":"Teehan Brendan","owner_url":"/insider/0001891900","role":"Officer (EVP, COO, Head of Commercial)","role_mark":"O","role_mark_label":"Officer (EVP, COO, Head of Commercial)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, COO, Head of Commercial","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":532.0,"shares_display":"532","price_per_share":17.1303,"price_display":"17.13","price_state":"stated","total_value":9113.3196,"total_display":"9,113.32","total_whole":"9,113","shares_owned_after":4549.0,"shares_owned_after_display":"4,549","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-09","filed_date":"2023-01-10","scope":"insider"},{"id":6455350,"accession":"0001209191-22-026937","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-026937","line_url":"/filing/0001209191-22-026937#line-2","is_derivative":false,"issuer_cik":"0001070494","issuer_name":"ACADIA PHARMACEUTICALS INC","issuer_ticker":"ACAD","issuer_name_source":null,"issuer_url":"/issuer/0001070494","owner_cik":"0001891900","owner_name":"Teehan Brendan","owner_display_name":"Teehan Brendan","owner_url":"/insider/0001891900","role":"Officer (EVP, COO, Head of Commercial)","role_mark":"O","role_mark_label":"Officer (EVP, COO, Head of Commercial)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, COO, Head of Commercial","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":552.0,"shares_display":"552","price_per_share":18.182,"price_display":"18.18","price_state":"stated","total_value":10036.464,"total_display":"10,036.46","total_whole":"10,036","shares_owned_after":3437.0,"shares_owned_after_display":"3,437","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-05-02","filed_date":"2022-05-03","scope":"insider"},{"id":6120676,"accession":"0001209191-22-013284","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-013284","line_url":"/filing/0001209191-22-013284#line-2","is_derivative":false,"issuer_cik":"0001070494","issuer_name":"ACADIA PHARMACEUTICALS INC","issuer_ticker":"ACAD","issuer_name_source":null,"issuer_url":"/issuer/0001070494","owner_cik":"0001891900","owner_name":"Teehan Brendan","owner_display_name":"Teehan Brendan","owner_url":"/insider/0001891900","role":"Officer (EVP, COO, Head of Commercial)","role_mark":"O","role_mark_label":"Officer (EVP, COO, Head of Commercial)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, COO, Head of Commercial","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":472.0,"shares_display":"472","price_per_share":23.8,"price_display":"23.80","price_state":"stated","total_value":11233.6,"total_display":"11,233.60","total_whole":"11,234","shares_owned_after":2422.0,"shares_owned_after_display":"2,422","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-02-23","filed_date":"2022-02-25","scope":"insider"},{"id":6423226,"accession":"0001209191-22-002751","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-002751","line_url":"/filing/0001209191-22-002751#line-2","is_derivative":false,"issuer_cik":"0001070494","issuer_name":"ACADIA PHARMACEUTICALS INC","issuer_ticker":"ACAD","issuer_name_source":null,"issuer_url":"/issuer/0001070494","owner_cik":"0001891900","owner_name":"Teehan Brendan","owner_display_name":"Teehan Brendan","owner_url":"/insider/0001891900","role":"Officer (EVP, COO, Head of Commercial)","role_mark":"O","role_mark_label":"Officer (EVP, COO, Head of Commercial)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, COO, Head of Commercial","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":538.0,"shares_display":"538","price_per_share":23.05,"price_display":"23.05","price_state":"stated","total_value":12400.9,"total_display":"12,400.90","total_whole":"12,401","shares_owned_after":1788.0,"shares_owned_after_display":"1,788","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-01-06","filed_date":"2022-01-10","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":16,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":16,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":16},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001070494","name":"ACADIA PHARMACEUTICALS INC","url":"/issuer/0001070494","role":"Officer (EVP, COO, HEAD OF COMMERCIAL)","n_filings":16,"first_seen":"2022-01-10","last_seen":"2024-11-19"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001891900","retrieved_at":"2026-08-25T08:29:37+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}